LINP1 and glioma: LINC00707 has a pro-oncogenic role and promotes cell proliferation in cancers such as LUAD (Ma et al., 2018), osteosarcoma, BC (Yuan et al., 2020), CC (Guo et al., 2021), bladder cancer (Gao and Ji, 2021), glioma (Liu and Hu, 2020), HCC (Tu et al., 2019; Wang et al., 2019), and clear cell renal cell carcinoma (Pang et al., 2020).